InfuSystem Holdings (INFU) EBITDA (2010 - 2026)

InfuSystem Holdings has reported EBITDA for 17 years, with the latest figure at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 299.03% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (up 175.54% YoY), and the FY2025 full-year result was $6.1 million, up 155.6% from the prior year.
• EBITDA for Q1 2026 stood at $1.0 million, down from $2.0 million in the prior quarter.
• The five-year high for EBITDA was $2.4 million in Q2 2025, with the low at -$904000.0 in Q1 2024.
• Historically, EBITDA has averaged $658000.0 across 5 years, with a median of $716000.0 in 2024.
• The largest YoY upside for EBITDA was 2790.48% in 2023 against a maximum downside of 15700.0% in 2023.
• InfuSystem Holdings' EBITDA stood at -$3000.0 in 2022, then plunged by 15700.0% to -$474000.0 in 2023, then surged by 356.54% to $1.2 million in 2024, then soared by 61.1% to $2.0 million in 2025, then plunged by 47.58% to $1.0 million in 2026.
• The last three EBITDA figures came in at $1.0 million (Q1 2026), $2.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.